- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07077694
- Original Trial
Artificial Intelligence to Detect Missed Root Canals in Previously Treated Lower Back Teeth Using 3D Dental Imaging (CBCT) (cone beam CT)
Accuracy of Artificial Intelligence Technology to Detect the Presence of Missed Canals of Endodontically Treated Mandibular Second Molar : Diagnostic Accuracy Experimental Study
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt, 11835
- Faculty of Oral and Dental Medicine future university
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 1) Patients must be medically free from any systemic disease that can affect root canal treatment.
2) Age range of the patient should be between 18 - 50 years old. 3) No sex predilection. 4) Patients must have good oral hygiene. 5) Patients with root canal-treated teeth. 6) Restorable teeth. 7) Positive patient acceptance for participating in the study. 8) Patients can sign informed consent.
Exclusion Criteria:
- 1) Patients with very poor oral hygiene. 2) Patients above 50 years and below 18 years. 3) Pregnant women after taking detailed history and pregnancy test must be in the first visit.
4) Psychologically disturbed patients. 5) Tooth periodontally affected with grade 2 or 3 mobility. 6) Non restorable teeth. 7) Tooth with abnormal anatomy and calcified canals.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Presence of missed canals
|
if Retreatment was needed, local anesthesia using 1.8 ml (one cartridge) of 4% articaine with 1:100,000 epinephrine local anesthetic solution, administered with end -loading cartridge aspirating syringe and a 27-gauge long needle.
Under rubber dam isolation, All carious tissue and existing coronal restorations were thoroughly removed using a round bur, an endodontic access cavity, canal preparation and removal of existing root canal filling, irrigation with 2.6% NAOCL and saline, determining the working length using apex locator and PA radiograph, to be 0.5 to 1 mm shorter than radiographic apex, Drying the canal with paper point and obturation to achieve a dense, well adapted Monoblock obturation.
A post-obturation periapical radiograph was taken to confirm the quality of the fill in terms of length, density, then sealed by a temporary restorative material.
Other Names:
|
|
Active Comparator: Morphological variation
|
if Retreatment was needed, local anesthesia using 1.8 ml (one cartridge) of 4% articaine with 1:100,000 epinephrine local anesthetic solution, administered with end -loading cartridge aspirating syringe and a 27-gauge long needle.
Under rubber dam isolation, All carious tissue and existing coronal restorations were thoroughly removed using a round bur, an endodontic access cavity, canal preparation and removal of existing root canal filling, irrigation with 2.6% NAOCL and saline, determining the working length using apex locator and PA radiograph, to be 0.5 to 1 mm shorter than radiographic apex, Drying the canal with paper point and obturation to achieve a dense, well adapted Monoblock obturation.
A post-obturation periapical radiograph was taken to confirm the quality of the fill in terms of length, density, then sealed by a temporary restorative material.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Presence of missed canals
Time Frame: Pre Operative and At the end of the treatment within 1 week
|
Pre Operative and At the end of the treatment within 1 week
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Morphological variation
Time Frame: Pre Operative and At the end of the treatment within 1 week
|
Pre Operative and At the end of the treatment within 1 week
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- FUE.REC(47)11-2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.